| Turkey | Austria | Spain | |
| Immunotherapy with Keytruda (Pembolizumab) | from $3,300 | from $15,000 | from $15,000 |
Day 1
Day 2
Day 3
Day 4-5
Day 6
Day 7
Weeks 2-4
Please note that each patient"s experience may vary, and you should always follow the advice of your healthcare provider.
Professor Bosch leads global research in Chronic Lymphocytic Leukemia (CLL) and lymphoma treatments, with over 80 active clinical trials.
Dr. Jesus Soberino is a clinical oncologist at Hospital Quiron Barcelona. He focuses on breast cancer and melanoma treatments. Dr. Soberino is a member of the Breast Cancer and Melanoma Units at Vall d’Hebron.
Dr. Joan Albanell Mestres is a leading oncologist at Hospital HM Nou Delfos in Barcelona. He heads the breast cancer program at HM Delfos. Dr. Albanell Mestres also directs oncology services at Mar Health Park. He conducted oncology research on telomerase in New York. His work is cited more than 9,000 times in medical literature.
Dr. Agusti Barnadas Molins is the chief breast cancer specialist at Teknon Oncology Institute in Barcelona. He has directed more than 70 research projects on breast cancer and gynecological oncology. Dr. Barnadas Molins treats tumors using chemotherapy, gland therapy, and immunotherapy. He practices at JCI-accredited Centro Médico Teknon.